EIF3J expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.68689999968663E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.26200000000387E-06 |
Normal-vs-Stage2 |
1.561590E-02 |
Normal-vs-Stage3 |
1.90350000206507E-08 |
Normal-vs-Stage4 |
2.93790000005512E-06 |
Stage1-vs-Stage2 |
9.050400E-01 |
Stage1-vs-Stage3 |
6.962900E-03 |
Stage1-vs-Stage4 |
1.267000E-01 |
Stage2-vs-Stage3 |
1.514000E-01 |
Stage2-vs-Stage4 |
3.538600E-01 |
Stage3-vs-Stage4 |
4.829600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.16940000028221E-07 |
Normal-vs-AfricanAmerican |
5.5605000004455E-07 |
Normal-vs-Asian |
4.778200E-02 |
Caucasian-vs-AfricanAmerican |
1.614000E-01 |
Caucasian-vs-Asian |
8.342000E-01 |
AfricanAmerican-vs-Asian |
7.074400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.26710000047936E-07 |
Normal-vs-Female |
2.15379999999321E-05 |
Male-vs-Female |
3.064600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.034200E-04 |
Normal-vs-Age(41-60Yrs) |
3.54639999999851E-05 |
Normal-vs-Age(61-80Yrs) |
1.16830000007617E-07 |
Normal-vs-Age(81-100Yrs) |
4.153500E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.520400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.191800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.900400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.043200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.893000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.412800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.888410E-01 |
Normal-vs-Grade 2 |
1.516230E-03 |
Normal-vs-Grade 3 |
7.77319986156044E-10 |
Normal-vs-Grade 4 |
2.48399999458471E-08 |
Grade 1-vs-Grade 2 |
7.177000E-01 |
Grade 1-vs-Grade 3 |
9.502200E-02 |
Grade 1-vs-Grade 4 |
4.838400E-02 |
Grade 2-vs-Grade 3 |
3.195600E-03 |
Grade 2-vs-Grade 4 |
2.879700E-03 |
Grade 3-vs-Grade 4 |
2.053400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.424700E-03 |
Normal-vs-ccB subtype |
1.74439995781484E-09 |
ccA subtype-vs-ccB subtype |
1.70190999999598E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.0594999999558E-06 |
Normal-vs-N1 |
9.404800E-03 |
N0-vs-N1 |
8.746800E-01 |
|
|